Chemotherapy plus ponatinib: a new standard for Ph-positive ALL?

被引：3
|
作者：
Thomas, Xavier [1 ]
机构：
[1] Lyon Sud Hosp, Hosp Civils Lyon, Hematol, F-69495 Pierre Benite, France
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 15期
关键词：
ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; IMATINIB; RESISTANCE; INHIBITOR; PHASE-2;
D O I：
10.1016/S1470-2045(15)00247-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1451 / 1453
页数：4
相关论文
共 50 条
  • [1] Ponatinib: hope for patients with CML or Ph-positive ALL?
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (13): : E588 - E588
  • [2] Ponatinib (Iclusig) for CML and Ph plus ALL
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1424): : 71 - 72
  • [3] Ph-positive ALL: will we still need chemotherapy and stem cell transplantion?
    Foa, Robin
    LEUKEMIA RESEARCH, 2018, 73 : S5 - S6
  • [4] Dasatinib-Blinatumomab for Ph-Positive ALL
    Foa, Robin
    Chiaretti, Sabina
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 384 - 384
  • [5] PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: IS CHEMOTHERAPY NECESSARY?
    Foa, Robin
    LEUKEMIA RESEARCH, 2017, 61 : S4 - S5
  • [6] Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemia
    Marchesi, Francesco
    Salvatorelli, Emanuela
    Renzi, Daniela
    Mengarelli, Andrea
    Minotti, Giorgio
    Menna, Pierantonio
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : E15 - +
  • [7] Leukemia cutis in a Ph plus ALL patient treated with ponatinib
    Pileri, Alessandro
    Papayannidis, Cristina
    Messori, Stefano
    Bacci, Francesco
    Sagramoso, Carlo A.
    Martinelli, Giovanni
    Patrizi, Annalisa
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (05): : 730 - 732
  • [8] Successful Molecular Remission with Ponatinib in a 3-year-old Girl with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-Positive ALL)
    Tanimura, Kazuki
    Yamasaki, Kai
    Okuhiro, Yuki
    Hira, Kouta
    Nitani, Chika
    Okada, Keiko
    Fujisaki, Hiroyuki
    Matsumoto, Kana
    Hara, Junichi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S33 - S33
  • [9] Ikaros isoform 6 expression in Ph-positive ALL.
    Yagi, T
    Hibi, S
    Takanashi, M
    Imamura, T
    Tabata, Y
    Horiike, S
    Taniwaki, M
    Sawada, T
    Imashuku, S
    BLOOD, 1999, 94 (10) : 187B - 187B
  • [10] Ponatinib vs Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) ALL: PhALLCON Study
    Jabbour, Elias
    Martinelli, Giovanni
    Vignetti, Marco
    Ribera, Jose-Maria
    Gomez-Almaguer, David
    Minami, Yosuke
    Xu, Jing
    Srivastava, Shouryadeep
    Neumann, Frank
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S194 - S194
12345